Analytical Data
-
基因名
LRRC3C
- Application
-
别名
LRRC3C；Leucine-rich repeat-containing Protein 3C
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
A6NJW4
-
表达区间
1-275aa
-
氨基酸序列
MRMTSSSFVSYCTPGLCQFMAMLPTAGHLLPLLLVIGTGGTVPSPQVPPRGCYVAKEAGERTFRCSQAGLSAVPSGIPNDTRKLYLDANQLASVPAGAFQHLPVLEELDLSHNALAHLSGAAFQGLEGTLRHLDLSANQLASVPVEAFVGLQIQVNLSANPWHCDCALQEVLRQVRLVPGTGTGIVCGSGARPDLVGQEFLLLAGEEELCGSGWGGARRSTDVALLVTMGGWLTLMVAYLVHYVWQNRDETRRSLKRAPVLPVRSEDSSILSTVV
-
分子量
29.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LRRC3C (Leucine-Rich Repeat Containing 3C) is a member of the leucine-rich repeat protein family, which plays essential roles in various cellular processes, including cell signaling, adhesion, and immune response. Recent studies have implicated LRRC3C in the regulation of key biological functions, such as cell proliferation, differentiation, and apoptosis. Given its potential involvement in various diseases, including cancer and autoimmune disorders, understanding the role and mechanism of action of LRRC3C has become increasingly important. Recombining LRRC3C into a protein form allows researchers to investigate its structural properties, interaction with other proteins, and functional implications in greater detail. Additionally, recombinant LRRC3C can serve as a valuable tool for developing therapeutic strategies aimed at modulating its activity, providing insights that could lead to novel interventions in diseases where LRRC3C is a contributing factor. Overall, the study of recombinant LRRC3C protein holds significant promise for advancing our understanding of its biological roles and potential therapeutic applications.
